Finance

Lists
524572:BOM
Pharmaids Pharmaceuticals Ltd
₹30.87
+1.21%
(+0.37) 1D
Oct 9, 3:30:00 PM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for 524572...
Open
₹32.40
High
₹32.48
Low
₹30.00
Mkt. cap
1.09B
Avg. vol.
3.56K
Volume
2.99K
52-wk high
₹53.90
52-wk low
₹25.60
EPS
-₹1.29
Shares outstanding
3.41M
No. of employees
127
Open
₹32.40
High
₹32.48
Low
₹30.00
Mkt. cap
1.09B
Avg. vol.
3.56K
Volume
2.99K
52-wk high
₹53.90
52-wk low
₹25.60
EPS
-₹1.29
Shares outstanding
3.41M
No. of employees
127
News stories
From web sources and news partners
About Pharmaids Pharmaceuticals Ltd
CEO-
Employees127
Founded1989
Headquarters-
SectorPharmaceutical industry
Last report
Aug 12, 2026
Fiscal period
Q1 2027
- / -
Revenue / Est. (INR)
41.21M / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
86.05M
54.30M
71.84M
41.21M
Cost of goods sold
75.50M
23.48M
45.15M
16.17M
Cost of revenue
75.50M
23.48M
45.15M
16.17M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
31.81M
32.83M
76.78M
24.66M
Operating expense
68.44M
60.62M
34.80M
37.34M
Total operating expenses
143.95M
84.10M
79.94M
53.52M
Operating income
-57.90M
-29.80M
-8.11M
-12.30M
Other non operating income
2.22M
760.00K
-2.73M
483.00K
EBT including unusual items
-36.57M
-40.22M
-14.56M
24.14M
EBT excluding unusual items
-66.45M
-36.22M
-12.62M
-17.86M
Income tax expense
-11.29M
-13.76M
-3.71M
5.43M
Effective tax rate
30.87%
34.20%
25.48%
22.49%
Other operating expenses
31.96M
23.04M
-46.75M
7.83M
Net income
-24.80M
-24.79M
-18.09M
22.05M
Net profit margin
-28.83%
-45.65%
-25.18%
53.51%
Earnings per share
-
-
-
-
Interest and investment income
-
-
1.54M
-
Interest expense
-10.77M
-7.18M
-4.36M
-6.04M
Net interest expenses
-10.77M
-7.18M
-2.82M
-6.04M
Depreciation and amortization charges
4.68M
4.76M
4.77M
4.86M
EBITDA
-52.53M
-25.07M
-4.50M
-7.23M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps